on November 19, 2007
Published online before print November 19, 2007, doi: 10.1161/CIRCULATIONAHA.107.694273
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on February 5, 2007
From McMaster University, Hamilton, Canada (F.A.S.); University of Massachusetts Medical School, Worcester (F.A.S., J.M.G., R.J.G., G.F.); Cardiovascular Center, University of Michigan, Ann Arbor (M.M.); Duke University Medical Center, Durham, NC (C.B.G.); Hôpital Bichat-Claude Bernard, Paris, France (P.G.S.); Terrence Donnelly Heart Centre, St Michael’s Hospital, University of Toronto, and Canadian Heart Research Centre, Toronto, Ontario, Canada (S.G.G.); Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); and Cardiovascular Research, University of Edinburgh, Edinburgh, Scotland (K.A.A.F.). * To whom correspondence should be addressed. E-mail: fspence{at}mcmaster.ca.
Background—Analyses from randomized controlled trials suggest that bleeding in patients with acute myocardial infarction is associated with poor outcomes. Because these data are not generalizable to all patients with acute myocardial infarction, we sought to better understand the scope of this problem in a "real-world" setting. Methods and Results—We examined the frequency of major bleeding in 40 087 patients with acute myocardial infarction enrolled in the Global Registry of Acute Coronary Events. Regression analyses were used to examine the association between patient and treatment characteristics, bleeding, and hospital and postdischarge outcomes. Major bleeding occurred in 2.8% of patients. These patients were older, more severely ill, and more likely to undergo invasive procedures. Patients with bleeding were more likely to die during hospitalization (hazard ratio, 1.9; 95% confidence interval, 1.6 to 2.2) but not after discharge (hazard ratio, 0.8; 95% confidence interval, 0.6 to 1.0) than patients who did not bleed. Continuation of antithrombotic therapies after day 1 was lower in patients who experienced early bleeding. Moreover, in patients who bled, hospital mortality was increased in those who discontinued aspirin, thienopyridines, or low–molecular-weight heparins. Conclusions—Major bleeding occurred in 1 in 35 patients with acute myocardial infarction; these patients accounted for
Accepted on October 2, 2007
Does Comorbidity Account for the Excess Mortality in Patients With Major Bleeding in Acute Myocardial Infarction?
Frederick A. Spencer MD*,
10% of all hospital deaths. Nevertheless, risk of hospital mortality associated with bleeding was much lower than reported in randomized controlled trials. These data suggest that although bleeding may be causally related to adverse outcomes in some patients in the real-world setting, it is often merely a marker for patients at higher risk for adverse outcomes.
Key words: death • hemorrhage • mortality • myocardial infarction
This article has been cited by other articles:
 |
|
 |
|
  K. A.A. Fox, K. Carruthers, Ph. G. Steg, A. Avezum, C. B. Granger, G. Montalescot, S. G. Goodman, J. M. Gore, A. L. Quill, K. A. Eagle, et al. Has the frequency of bleeding changed over time for patients presenting with an acute coronary syndrome? The Global Registry of Acute Coronary Events Eur. Heart J., December 8, 2009; (2009) ehp499v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Eikelboom, D. J. Quinlan, and M. O'Donnell Major Bleeding, Mortality, and Efficacy of Fondaparinux in Venous Thromboembolism Prevention Trials Circulation, November 17, 2009; 120(20): 2006 - 2011. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Jolic{oelig}ur, W. W. O'Neill, A. Hellkamp, C. W. Hamm, D. R. Holmes Jr., H. R. Al-Khalidi, M. R. Patel, F. J. Van de Werf, K. Pieper, P. W. Armstrong, et al. Transfusion and mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention Eur. Heart J., November 1, 2009; 30(21): 2575 - 2583. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Serebruany, S. V. Rao, M. A. Silva, J. L. Donovan, A. O. Kannan, L. Makarov, S. Goto, and D. Atar Correlation of inhibition of platelet aggregation after clopidogrel with post discharge bleeding events: assessment by different bleeding classifications Eur. Heart J., October 23, 2009; (2009) ehp434v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. van Hattum, A. Algra, J. A. Lawson, B. C. Eikelboom, F. L. Moll, and M. J.D. Tangelder Bleeding Increases the Risk of Ischemic Events in Patients With Peripheral Arterial Disease Circulation, October 20, 2009; 120(16): 1569 - 1576. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Ahmed, W. D. Piper, D. Malenka, P. VerLee, J. Robb, T. Ryan, M. Herne, W. Phillips, and H. L. Dauerman Significantly Improved Vascular Complications Among Women Undergoing Percutaneous Coronary Intervention: A Report From the Northern New England Percutaneous Coronary Intervention Registry Circ Cardiovasc Interv, October 1, 2009; 2(5): 423 - 429. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Doyle, C. S. Rihal, D. A. Gastineau, and D. R. Holmes Jr Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention implications for contemporary practice. J. Am. Coll. Cardiol., June 2, 2009; 53(22): 2019 - 2027. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Mehran, S. J. Pocock, G. W. Stone, T. C. Clayton, G. D. Dangas, F. Feit, S. V. Manoukian, E. Nikolsky, A. J. Lansky, A. Kirtane, et al. Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial Eur. Heart J., June 2, 2009; 30(12): 1457 - 1466. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D Brieger, K A A Fox, G FitzGerald, K A Eagle, A Budaj, A Avezum, C B Granger, B Costa, F A Anderson Jr, P. G Steg, et al. Predicting freedom from clinical events in non-ST-elevation acute coronary syndromes: the Global Registry of Acute Coronary Events Heart, June 1, 2009; 95(11): 888 - 894. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Subherwal, R. G. Bach, A. Y. Chen, B. F. Gage, S. V. Rao, L. K. Newby, T. Y. Wang, W. B. Gibler, E. M. Ohman, M. T. Roe, et al. Baseline Risk of Major Bleeding in Non-ST-Segment-Elevation Myocardial Infarction: The CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Bleeding Score Circulation, April 14, 2009; 119(14): 1873 - 1882. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Cheng, D. A. Morrow, S. Sloan, E. M. Antman, and M. S. Sabatine Predictors of Initial Nontherapeutic Anticoagulation With Unfractionated Heparin in ST-Segment Elevation Myocardial Infarction Circulation, March 10, 2009; 119(9): 1195 - 1202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Budaj, J. W. Eikelboom, S. R. Mehta, R. Afzal, S. Chrolavicius, J.-P. Bassand, K. A.A. Fox, L. Wallentin, R. J.G. Peters, C. B. Granger, et al. Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes Eur. Heart J., March 2, 2009; 30(6): 655 - 661. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. Shishehbor, S. Madhwal, V. Rajagopal, A. Hsu, P. Kelly, H. S. Gurm, S. R. Kapadia, M. S. Lauer, and E. J. Topol Impact of Blood Transfusion on Short- and Long-Term Mortality in Patients With ST-Segment Elevation Myocardial Infarction J. Am. Coll. Cardiol. Intv., January 1, 2009; 2(1): 46 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Antoniucci The balance between bleeding and ischaemic complications in percutnaeous coronary intervention practice Eur. Heart J. Suppl., December 1, 2008; 10(suppl_J): J21 - J25. [Full Text] [PDF]
|
|
|
|
|
|
L. C Correia, M. S Rocha, M. Teixeira, T. Cerqueira, A. Vasconcelos, S. Merelles, T. Reis, and J. P. Esteves Abstract 2027: Validation of a Bleeding Risk Score for Acute Coronary Syndromes Circulation, October 28, 2008; 118(18_MeetingAbstracts): S_660 - S_660.
|
|
|
|
|
|
R. P. Giugliano and E. Braunwald The Year in Non-ST-Segment Elevation Acute Coronary Syndrome J. Am. Coll. Cardiol., September 23, 2008; 52(13): 1095 - 1103. [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Morrow Antithrombotic Therapy to Support Primary PCI N. Engl. J. Med., May 22, 2008; 358(21): 2280 - 2282. [Full Text] [PDF]
|
|
|
|
 |
|
 What Is the Impact of Bleeding After Acute MI Treatment? Journal Watch Cardiology, February 6, 2008; 2008(206): 3 - 3. [Full Text]
|
|
|
|
|
|
P. B. Berger and S. V. Manoukian Bleeding Is Bad.... Isn't It? Circulation, December 11, 2007; 116(24): 2776 - 2778. [Full Text] [PDF]
|
|